Burning Rock Biotech (BNR) Shares Outstanding (Weighted Average) (2019 - 2025)

Burning Rock Biotech's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) fell 79.5% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $2.4 million (down 79.5% YoY), while the FY2025 annual figure was $2.4 million, down 79.5% from the prior year.
• Shares Outstanding (Weighted Average) was $2.4 million for Q4 2025 at Burning Rock Biotech, down from $11.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $17.6 million in Q2 2022 to a low of $557.12 in Q2 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $8.6 million across 5 years, with a median of $11.9 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Weighted Average) slumped 99.99% in 2021, then jumped 3157397.04% in 2022.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $13.6 million in 2021, then decreased by 10.41% to $12.2 million in 2022, then sank by 80.24% to $2.4 million in 2023, then jumped by 395.32% to $11.9 million in 2024, then plunged by 79.5% to $2.4 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $2.4 million (Q4 2025), $11.9 million (Q4 2024), and $2.4 million (Q4 2023), per Business Quant data.